| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.87B | $1.75B | $2.24B |
| YoY Revenue Growth % | +6.8% | -21.8% | — |
| Gross Profit | $886.7M | $778.0M | — |
| Gross Margin % | 47.3% | 44.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $150.2M | $97.5M | -$66.8M |
| Operating Margin % | 8.0% | 5.6% | -3.0% |
| Net Income (GAAP) | $95.8M | $45.2M | -$38.5M |
| EBITDA (Normalized) | $161.8M | $113.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $140.0M | $180.1M | $121.8M |
| Capital Expenditures (CapEx) | $14.5M | $20.2M | — |
| Free Cash Flow (FCF) | $125.5M | $159.9M | $121.8M |
| FCF Margin % | 6.7% | 9.1% | 5.4% |
| Return on Invested Capital (ROIC %) | 12.4% | 8.7% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $546.7M | $568.0M | — |
| Total Stockholders' Equity | $408.0M | $312.9M | — |